Liquid Biopsy in Oncohematology: Ready for clinic?

Dr. Sven Borchmann from the University of Cologne will guide participants through the revolutionary world of liquid biopsies as applied to B cell lymphoma. Attendees will gain a deep understanding of Minimal Residual Disease (MRD) and its profound implications in oncohematology, particularly aggressive B cell lymphoma. Dr. Borchmann will shed light on the innovative techniques for MRD measurement using circulating tumor DNA and provide a glimpse into the exciting future prospects in this field. 

Prof. Mattia D'Agostino from the University of Turin, focuses on liquid biopsy techniques in the context of multiple myeloma and precision medicine. Prof. D'Agostino will unravel the diverse techniques used in liquid biopsies and their applicability in multiple myeloma. Participants will discover how liquid biopsies are reshaping the landscape of multiple myeloma diagnosis and their critical role in monitoring MRD in this patient population. The session will conclude by looking ahead at the potential of liquid biopsies to revolutionize precision medicine in the context of multiple myeloma, promising a forward-thinking perspective for all attendees.